Rx Cost Containment At CareFirst Driven By Physician Incentives
This article was originally published in The Pink Sheet Daily
Executive Summary
Legal changes that allow more data sharing can encourage value-based contracting, Executive VP-Medical Affairs Blum says
You may also be interested in...
US Retail Drug Spending Growth Slowing With No New Sovaldis In Sight
Rate of growth in prescription drug spending is expected to average 6.7% per year from 2016 through 2025, National Health Expenditures report from CMS projects.
Making The Case For A Legislative Deal On Drug Pricing
Drawing on 24 years as a legislator and another 16 years as a leading lobbyist for biopharma, Jim Greenwood sees an opportunity for industry to put drug pricing ‘behind us’ with a legislative compromise.
Insulin Report Revives Senate Finance Committee Push On Drug Pricing Legislation
Report released as soon-to-be committee chair Ron Wyden, D-OR, assembles plans for drug pricing legislation in the new Democratic-controlled Senate.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: